313
Views
39
CrossRef citations to date
0
Altmetric
Review

Recent advances in amphotericin B delivery strategies for the treatment of leishmaniases

, , &
Pages 1063-1079 | Received 16 May 2019, Accepted 20 Aug 2019, Published online: 30 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Adnan Anjum, Kanwal Shabbir, Fakhar Ud Din, Shumaila Shafique, Syed Saoud Zaidi, Ali H Almari, Taha Alqahtani, Aleena Maryiam, Muhammad Moneeb Khan, Adel Al Fatease, Sidra Bashir & Gul Majid Khan. (2023) Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of Cutaneous leishmaniasis. Drug Delivery 30:1.
Read now
Ízola Morais de Medeiros Ramalho, Daniel Torres Pereira, Giovanna Brunelly Lima Galvão, Danielle Teixeira Freire, Lucas Amaral-Machado, Éverton do Nascimento Alencar & Eryvaldo Socrates Tabosa do Egito. (2021) Current trends on cannabidiol delivery systems: where are we and where are we going?. Expert Opinion on Drug Delivery 18:11, pages 1577-1587.
Read now
Jair Téllez, Maria Clara Echeverry, Ibeth Romero, Andrea Guatibonza, Guilherme Santos Ramos, Ana Carolina Borges De Oliveira, Frédéric Frézard & Cynthia Demicheli. (2021) Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives. Journal of Liposome Research 31:2, pages 169-176.
Read now
Jéssica Rebouças-Silva, Maraine Catarina Tadini, Danielle Devequi-Nunes, Ana Luíza Mansur, Paulo S Silveira-Mattos, Camila I de Oliveira, Fábio R Formiga, Andresa A Berretta, Franciane Marquele-Oliveira & Valéria M Borges. (2020) Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of Leishmania braziliensis Infection. International Journal of Nanomedicine 15, pages 8659-8672.
Read now

Articles from other publishers (35)

Kengo Banshoya, Yoshiharu Kaneo, Makoto Shirakawa, Yuhzo Hieda, Aoi Machida, Masatoshi Ohnishi & Tetsuro Tanaka. (2023) Preparation and in vitro evaluation of amphotericin B-loaded nano-formulations for both intravenous and ophthalmic administration using 3-aminophenylboronic acid-conjugated styrene-maleic acid copolymers. Journal of Drug Delivery Science and Technology 90, pages 105176.
Crossref
Annapurna Padaraju, Falguni Dwivedi & Gautam Kumar. (2023) Microemulsions, nanoemulsions and emulgels as carriers for antifungal antibiotics. Therapeutic Delivery.
Crossref
Donya Nikaein, Dariush Shirani, Aghil Sharifzadeh, Ava Alavi & Ali Reza Khosravi. (2023) Antifungal susceptibility profile of yeasts isolated from the oral cavity of cats. Veterinary Medicine and Science 9:6, pages 2414-2419.
Crossref
Daniela Peruzzu, Katia Fecchi, Giulietta Venturi & Maria Cristina Gagliardi. (2023) Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox. International Journal of Molecular Sciences 24:10, pages 8896.
Crossref
Fang Zhang, Jingjing Zhang & Weifen Zhang. (2023) Recent advances in nanotechnology for the treatment of fungal keratitis. European Journal of Ophthalmology, pages 112067212311746.
Crossref
Mudigunda V Sushma, Sri Amruthaa Sankaranarayanan, Veeresh Bantal, Deepak B Pemmaraju & Aravind Kumar Rengan. (2023) Ethosomal Nanoformulations for Combinational Photothermal Therapy of Fungal Keratitis. Advanced Therapeutics 6:5.
Crossref
Camila S. Freitas, Daniela P. Lage, Amanda S. Machado, Danniele L. Vale, Vívian T. Martins, Jamille M.O. Cardoso, João A. Oliveira-da-Silva, Thiago A.R. Reis, Grasiele S.V. Tavares, Fernanda F. Ramos, Fernanda Ludolf, Isabela A.G. Pereira, Raquel S. Bandeira, Ricardo T. Fujiwara, Lílian L. Bueno, Bruno M. Roatt, Miguel A. Chávez-Fumagalli & Eduardo A.F. Coelho. (2023) Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis. Cytokine 164, pages 156143.
Crossref
Joao Henrique Ghilardi Lago & Luiz Felipe Domingues Passero. (2023) Recent Advances and Future Challenges in Drug Discovery for Leishmaniasis Based on Natural Products. Current Organic Chemistry 27:5, pages 379-383.
Crossref
Reza Boshrouyeh, Samar Amari, Mohammad Boshrouyeh Ghandashtani, Seyed Ebrahim Alavi & Hasan Ebrahimi Shahmabadi. (2023) A topical gel nanoformulation of amphotericin B (AmB) for the treatment of cutaneous leishmaniasis (CL). Journal of Sol-Gel Science and Technology 105:3, pages 768-780.
Crossref
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng & Wei He. (2023) Approved Nanomedicine against Diseases. Pharmaceutics 15:3, pages 774.
Crossref
Agnieszka Dróżdż, Dominika Kubera, Adrianna Sławińska-Brych, Arkadiusz Matwijczuk, Lidia Ślusarczyk, Grzegorz Czernel, Dariusz Karcz, Alina Olender, Agnieszka Bogut, Daniel Pietrzak, Wojciech Dąbrowski, Andrzej Stepulak, Alicja Wójcik-Załuska & Mariusz Gagoś. (2023) Synergistic Antifungal Interactions between Antibiotic Amphotericin B and Selected 1,3,4-thiadiazole Derivatives, Determined by Microbiological, Cytochemical, and Molecular Spectroscopic Studies. International Journal of Molecular Sciences 24:4, pages 3430.
Crossref
Gaëlle Lentini, Peter C. Dumoulin & Nicola S. Carter. 2023. Encyclopedia of Cell Biology. Encyclopedia of Cell Biology 371 385 .
Frédéric Frézard, Marta M. G. Aguiar, Lucas A. M. Ferreira, Guilherme S. Ramos, Thais T. Santos, Gabriel S. M. Borges, Virgínia M. R. Vallejos & Helane L. O. De Morais. (2022) Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations. Pharmaceutics 15:1, pages 99.
Crossref
Ellen Wasan, Tavonga Mandava, Pablo Crespo-Moran, Adrienne Nagy & Kishor M. Wasan. (2022) Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections. Pharmaceutics 14:11, pages 2316.
Crossref
Nergiz GÜRBÜZ ÇOLAK, Emel Öykü ÇETİN UYANIKGİL, Yusuf ÖZBEL & Seray TÖZ. (2022) The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis. Acta Parasitologica 67:3, pages 1354-1363.
Crossref
Juliane S. Lanza, Virginia M. R. Vallejos, Guilherme S. Ramos, Ana Carolina B. de Oliveira, Cynthia Demicheli, Luis Rivas, Sébastien Pomel, Philippe M. Loiseau & Frédéric Frézard. (2022) Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases. Pharmaceutics 14:8, pages 1743.
Crossref
Guilherme S. Ramos, Virgínia M. R. Vallejos, Gabriel S. M. Borges, Raquel M. Almeida, Izabela M. Alves, Marta M. G. Aguiar, Christian Fernandes, Pedro P. G. Guimarães, Ricardo T. Fujiwara, Philippe M. Loiseau, Lucas A. M. Ferreira & Frédéric Frézard. (2022) Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes. Pharmaceutics 14:5, pages 989.
Crossref
Akash Agarwal & BikashR Kar. (2022) Amphotericin-B in dermatology. Indian Dermatology Online Journal 13:1, pages 152.
Crossref
Anita Cohen & Nadine Azas. (2021) Challenges and Tools for In Vitro Leishmania Exploratory Screening in the Drug Development Process: An Updated Review. Pathogens 10:12, pages 1608.
Crossref
Alireza Keyhani, Iraj Sharifi, Ehsan Salarkia, Ahmad Khosravi, Razieh Tavakoli Oliaee, Zahra Babaei, Pooya Ghasemi Nejad Almani, Saeid Hassanzadeh, Reza Kheirandish, Mashid Mostafavi, Maryam Hakimi Parizi, Sodabeh Alahdin, Fatemeh Sharifi, Shahriar Dabiri, Simin Shamsi Meymandi, Ali Khamesipour, Abdollah Jafarzadeh & Mehdi Bamorovat. (2021) In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and multifunctional effects. International Immunopharmacology 101, pages 108274.
Crossref
Débora Faria Silva, Levi Eduardo Soares Reis, Marina Guimarães Carvalho Machado, Douglas Daniel Dophine, Vinicius Roberto de Andrade, Wanderson Geraldo de Lima, Margareth Spangler Andrade, José Mário Carneiro Vilela, Alexandre Barbosa Reis, Gwenaelle Pound-Lana, Simone Aparecida Rezende & Vanessa Carla Furtado Mosqueira. (2021) Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics 13:7, pages 1061.
Crossref
Marta de Lana & Rodolfo Cordeiro Giunchetti. (2021) Dogs as a Model for Chemotherapy of Chagas Disease and Leishmaniasis. Current Pharmaceutical Design 27:14, pages 1741-1756.
Crossref
Manuela Carvalheiro, Jennifer Vieira, Catarina Faria-Silva, Joana Marto & Sandra Simões. (2021) Amphotericin B-loaded deformable lipid vesicles for topical treatment of cutaneous leishmaniasis skin lesions. Drug Delivery and Translational Research 11:2, pages 717-728.
Crossref
Marium Azim, Saeed Ahmad Khan, Saleem Ullah, Shafiq Ullah & Syed Ishtiaq Anjum. (2021) Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review. PLOS Neglected Tropical Diseases 15:3, pages e0009099.
Crossref
Dong Wang, Wei Zhang, Jie-Xi Ju, Lu-Jia Wang, Ru-Yu Huang, Yan-Fang Xu, Hai-Lin Zhang & Jin-Long Qi. (2021) Gender differences in acute toxicity, toxicokinetic and tissue distribution of amphotericin B liposomes in rats. Toxicology Letters 338, pages 78-84.
Crossref
Douglas O. Escrivani, Gabriela C. Mattos, Bartira Rossi-Bergmann & Ariane J. Sousa-Batista. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery 181 217 .
Liwen Feng, Sébastien Pomel, Perle Latre de Late, Alexandre Taravaud, Philippe M. Loiseau, Louis Maes, Fidelis Cho-Ngwa, Christina A. Bulman, Chelsea Fischer, Judy A. Sakanari, Peter D. Ziniel, David L. Williams & Elisabeth Davioud-Charvet. (2020) Repurposing Auranofin and Evaluation of a New Gold(I) Compound for the Search of Treatment of Human and Cattle Parasitic Diseases: From Protozoa to Helminth Infections. Molecules 25:21, pages 5075.
Crossref
Ilaria Varotto-Boccazzi, Sara Epis, Irene Arnoldi, Yolanda Corbett, Paolo Gabrieli, Moira Paroni, Riccardo Nodari, Nicoletta Basilico, Luciano Sacchi, Marina Gramiccia, Luigi Gradoni, Vito Tranquillo & Claudio Bandi. (2020) Boosting immunity to treat parasitic infections: Asaia bacteria expressing a protein from Wolbachia determine M1 macrophage activation and killing of Leishmania protozoans. Pharmacological Research 161, pages 105288.
Crossref
Kengo Banshoya, Yoshiharu Kaneo, Tetsuro Tanaka, Shigechika Yamamoto & Hiroshi Maeda. (2020) Development of an amphotericin B micellar formulation using cholesterol-conjugated styrene-maleic acid copolymer for enhancement of blood circulation and antifungal selectivity. International Journal of Pharmaceutics 589, pages 119813.
Crossref
Fernando Almeida-Souza, Verônica Diniz da Silva, Gabriel Xavier Silva, Noemi Nosomi Taniwaki, Daiana de Jesus Hardoim, Camilla Djenne Buarque, Ana Lucia Abreu-Silva & Kátia da Silva Calabrese. (2020) 1,4-Disubstituted-1,2,3-Triazole Compounds Induce Ultrastructural Alterations in Leishmania amazonensis Promastigote: An in Vitro Antileishmanial and in Silico Pharmacokinetic Study. International Journal of Molecular Sciences 21:18, pages 6839.
Crossref
S. Gnat, D. Łagowski & A. Nowakiewicz. (2020) Major challenges and perspectives in the diagnostics and treatment of dermatophyte infections. Journal of Applied Microbiology 129:2, pages 212-232.
Crossref
Kirandeep Kaur, Parveen Kumar & Preeti Kush. (2020) Amphotericin B loaded ethyl cellulose nanoparticles with magnified oral bioavailability for safe and effective treatment of fungal infection. Biomedicine & Pharmacotherapy 128, pages 110297.
Crossref
Diana Berenguer, Maria Magdalena Alcover, Marcella Sessa, Lyda Halbaut, Carme Guillén, Antoni Boix-Montañés, Roser Fisa, Ana Cristina Calpena-Campmany, Cristina Riera & Lilian Sosa. (2020) Topical Amphotericin B Semisolid Dosage Form for Cutaneous Leishmaniasis: Physicochemical Characterization, Ex Vivo Skin Permeation and Biological Activity. Pharmaceutics 12:2, pages 149.
Crossref
Faustino & Pinheiro. (2020) Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy. Pharmaceutics 12:1, pages 29.
Crossref
Kinam Kim, Suk Jin Choi & Young Hyo Kim. (2019) A Case of Recurrent Nasal Mucormycosis Treated by Repetitive Surgical Debridement. Journal of Clinical Otolaryngology Head and Neck Surgery 30:2, pages 253-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.